^
Association details:
Evidence:
Evidence Level:
Sensitive: D – Preclinical
New
Title:

Targeting the human MUC1-C oncoprotein with an antibody-drug conjugate

Excerpt:
The mAb 3D1-MMAE antibody-drug conjugate (ADC) (a) kills MUC1-C–positive cells in vitro, (b) is nontoxic in MUC1-transgenic (MUC1.Tg) mice, and (c) is active against human HCC827 lung tumor xenografts. Humanized mAb (humAb) 3D1 conjugated to MMAE also exhibited antitumor activity in (a) MUC1.Tg mice harboring syngeneic MC-38/MUC1 tumors, (b) nude mice bearing human ZR-75-1 breast tumors, and (c) NCG mice engrafted with a patient-derived triple-negative breast cancer.
DOI:
https://doi.org/10.1172/jci.insight.99880